X

Trial Profile

Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2016

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pimecrolimus (Primary) ; Tacrolimus (Primary) ; Corticosteroids
Indications Atopic dermatitis
Focus Adverse reactions
Acronyms JOELLE
Sponsors Astellas Pharma

Most Recent Events

10 Nov 2016 New trial record
02 Nov 2016 Results (n=227359) accessing utilization of Topical Tacrolimus and Pimecrolimus in Europe were presented at the 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
01 Mar 2013 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com